Latest kidney cancer Stories
U.S. cancer researchers say they've determined outcomes of robot-assisted kidney cancer surgery are more beneficial to patients than open surgery. Medical scientists at the Fox Chase Cancer Center in Philadelphia led by Dr.
Fighting kidney cancer could be as easy as swapping your next steak for a plate of leafy greens, new research in the Journal of the American Dietetic Association shows.
- Afinitor more than doubled time without tumor growth and reduced the risk of disease progression or death by 67% compared with placebo - Only once-daily oral cancer treatment to directly target mTOR, a protein inside the cell that controls tumor cell division and blood vessel growth - Phase III trials underway to explore potential of Afinitor in multiple additional cancers EAST HANOVER, N.J., March 30 /PRNewswire/ -- Novartis announced today that Afinitor(R) (everolimus) tablets has been...
More Than 75 Percent of Patients Diagnosed Have Small Renal Cell Tumors; Safe Interventional Radiology Treatment Shown Near 100 Percent Effective in Destroying Localized Tumors, Says Johns Hopkins Study SAN DIEGO, March 9 /PRNewswire-USNewswire/ -- Freezing kidney tumors -- using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery -- should be the gold standard or first treatment option for all individuals with tumors...
Large-scale data mining of gene networks in fruit flies has led researchers to a sensitive and specific diagnostic biomarker for human renal cell carcinoma, the most common type of kidney cancer.
Kidney cancer is typically without symptoms until it has spread to other organs, when it is also the most difficult to treat. Newer chemotherapies show great promise for extending survival during later disease stages, but they can also be highly toxic.In one of the first discoveries of its kind, UC Davis Cancer Center researchers have identified ways to block a cancer gene's own repair mechanism and, in so doing, help make chemotherapy for kidney cancer more effective and better tolerated....
Antigenics Inc. (NASDAQ: AGEN) reported results for the quarter ended September 30, 2008.
U.S. researchers found aggressive, personalized treatment increases kidney cancer patient survival compared to the one-size-fits-all traditionally used.
Antigenics, a biotechnology company, has submitted a marketing authorization application to the European Medicines Agency requesting approval for Oncophage in earlier-stage, localized renal cell carcinoma under the conditional authorization provision.
Antigenics Inc. (NASDAQ: AGEN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) requesting approval for Oncophage(R) in earlier-stage, localized renal cell carcinoma (kidney cancer) under the conditional authorization provision.
- The governor of a province or people.